Cara Therapeutics (CARA)
$19.82
0.13 (0.66%)
17:09 EST
CARA Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
671.40M
PE Ratio
-12.71
EPS
-1.56
Volume (Avg. Vol.)
300,400
Day's Range
19.48 - 20.20
52-Week Range
8.88 - 22.60
Dividend & Yield
N/A (N/A)
CARA Stock Predictions, Articles, and Cara Therapeutics News
- From InvestorPlace
- From the Web
6 Cannabis Stocks to Buy as the U.S. Softens Its Stance
These 6 cannabis stocks show promise in the medical and recreational ends of the burgeoning marijuana sector, set to grow even more in 2021.
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
10 Marijuana Stocks That Could See 100% Gains, If Not More
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
3 Marijuana Stocks to Play the Future of Cannabis Medicine
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
Even with a Pharma Arm, Canopy Growth Stock Is About Recreational Use
It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.
5 Cannabis Stocks Set to Skyrocket — According to Wall Street’s Top Analysts
Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.
Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
With Trial Results Due, This Could Be a Breakout Year for Cara Stock
Putting in the work may pay off big for In 2018, setting up the clinical studies dominated Cara Therapeutics' activities. For 2019, the study results may drive Cara stock higher. stock
Cara Therapeutics Stock Could Outperform in 2019
CARA stock could be meaningfully boosted by drug development updates in 2019
The Trade War Could Be a Positive Catalyst for Cara Therapeutics Stock
Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.
9 Marijuana Stocks to Play the Pot Craze
Marijuana stocks like Cronos, Cannabis Sativa and Canopy Growth are just a handful of the names worth a closer look here.
Why Cara Therapeutics Stock Is Soaring Today
Cara Therapeutics (CARA) shares were up more than 11% on Wednesday as the company received good news regarding its latest clinical trial.
3 Stocks to Watch on Wednesday: Square Inc (SQ), Cara Therapeutics Inc (CARA) and Healthcare Services Group, Inc. (HCSG)
Square (SQ) continues its breathtaking 2017 rally Wednesday, Cara Therapeutics (CARA) jumps on trial results and Healthcare Services Group (HCSG) scores a post-earnings bump.
Why Best Buy Co Inc (BBY), Abercrombie & Fitch Co. (ANF) and Cara Therapeutics Inc (CARA) Are 3 of Today’s Worst Stocks
Too bad for Cara Therapeutics (CARA), Abercrombie & Fitch (ANF) and Best Buy (BBY) owners -- the market doesn't do do-overs.
Why Pandora Media Inc (P), Cara Therapeutics Inc (CARA) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks
Micron Technology (MU), Pandora (P) and Cara Therapeutics (CARA) all ended the trading week on a bearish foot, but for understandable reasons.
Why Cara Therapeutics Inc (CARA) Stock Is Plunging Today
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Marijuana Stocks: Cara Therapeutics Inc (CARA) Stock Soars on FDA Breakthrough Therapy Status
Cara Therapeutics (CARA) stock was flying high on Friday following good news from the U.S. Food and Drug Administration.
Why Sears Holdings Corp (SHLD), Cara Therapeutics Inc (CARA) and Exxon Mobil Corporation (XOM) Are 3 of Today’s Worst Stocks
Cara Therapeutics (CARA), Sears Holdings (SHLD) and Exxon Mobil (XOM) and the day and the week on a low note, though for understandable reasons.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold